Bone mineral density and its relationship to prolactin levels in patients taking antipsychotic treatment

Journal of Clinical Psychopharmacology

Volumn 25, Issue 3, 2005, Pages 259-261

  Howes, Oliver D ^a   Wheeler, Michael J ^b   Meaney, Anna Maria ^c   O'Keane, Veronica ^a   Fogelman, Ignac ^b   Blake, Glen ^b   Murray, Robin M ^a   Smith, Shubulade ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b ST THOMAS HOSPITAL   (United Kingdom)

^c BEAUMONT HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

AMISULPRIDE; CHLORPROMAZINE; FLUPENTIXOL; FLUPHENAZINE; HALOPERIDOL; NEUROLEPTIC AGENT; OLANZAPINE; OSTEOCALCIN; PIMOZIDE; PIPOTIAZINE; PROLACTIN; QUETIAPINE; RISPERIDONE; SULPIRIDE; TRIFLUOPERAZINE; ZIPRASIDONE; ZUCLOPENTHIXOL;

ADULT; ARTICLE; BONE DENSITY; BONE METABOLISM; CONTROLLED STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; ETHNIC DIFFERENCE; FEMALE; HIP; HUMAN; LUMBAR SPINE; MAJOR CLINICAL STUDY; MALE; OSTEOPOROSIS; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; RACE DIFFERENCE; RISK FACTOR; SCHIZOPHRENIA; SCORING SYSTEM; TREATMENT OUTCOME;

ADULT; AMBULATORY CARE; ANTIPSYCHOTIC AGENTS; BONE DENSITY; FEMALE; HUMANS; MALE; MIDDLE AGED; PROLACTIN; RISK FACTORS;

EID: 18844458606     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.jcp.0000162798.87249.4d     Document Type: Article

References (7)

1. Meaney AM, Smith S, Howes OD, et al. Effects of long-term prolactin-raising antipsychotic medication on bone mineral density in patients with schizophrenia. Br J Psychiatry. 2004;184:503-508.
2. Halbreich U, Rojansky N, Palter S, et al. Decreased bone mineral density in medicated psychiatric patients. Psychosom Med. 1995;57:485-491.
3. Abraham G, Halbreich U, Friedman RH, et al. Bone mineral density and prolactin associations in patients with chronic schizophrenia. Schizophr Res. 2003;59:17-18.
4. Abraham G, Paing WW, Kaminski J, et al. Effects of elevated serum prolactin on bone mineral density and bone metabolism in female patients with schizophrenia: a prospective study. Am J Psychiatry. 2003;160:1618-1620.
5. Kanis JA. Diagnosis of osteoporosis and assessment of fracture risk. Lancet. 2002;359:1929-1936.
6. Kelly TL. Bone mineral density reference databases for American men and women. J Bone Miner Res. 1990;5:249.
7. Looker AC, Wahner HW, Dunn WL, et al. Updated data on proximal femur bone mineral levels of US adults. Osteoporos Int. 1998;8:468-489.